---
title: The Administration and Study of COVID-19 Vaccines in Sweden
toc: true
plotly: true
menu:
    dashboard_menu:
        identifier: vaccines
        name: Vaccine administration in Sweden
        weight: 30
aliases:
    - /data_types/health_data/vaccines/
---

## General information on COVID-19 vaccines

Over the last two years, the COVID-19 pandemic has challenged societies and healthcare systems worldwide. In response, vaccines and therapeautic treatments have been rapidly developed. To date (October 2022), the [European Medicines Agency (EMA)](https://www.ema.europa.eu/en) has approved six vaccines against COVID-19:

- **Comirnaty** - produced by Pfizer/BioNTech, approved on 21st December 2020. New updates variants for boosters are available (Oct 2022), for example, Comirnaty Original/Omicron BA.1 and Comirnaty Original/Omicron BA.4-5
- **Spikevax** - produced by Moderna, approved on 6th January 2021. New updated variant for boosters is available (Oct 2022), Spikevax bivalent Original/Omicron BA.1.
- **Vaxzevria (previously called COVID-19 Vaccine AstraZeneca)** - produced by AstraZeneca, approved on 29th January 2021.
- **Jcovden (previously COVID-19 Vaccine Janssen)** - produced by Janssen, approved on 11th March 2021.
- **Nuvaxovid** - produced by Novavax, approved on 20th December 2021.
- **COVID-19 Vaccine Valneva** - produced by Valneva Austria GmbH, approved on 24th June 2022.

New vaccines are developed regularly, and are reviewed by EMA. Please refer to EMA's page on [COVID-19 vaccines](https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/covid-19-vaccines) to see the latest information on which vaccine are approved, which have submitted marketing authorisation, and which are under rolling review. New vaccines remain under rolling review until EMA have reviewed clinical trial data and determined that there is sufficient evidence to enable developers to apply for marketing authorisation.

As of October 2022, only **Comirnaty** (Pfizer/BioNTech), **Spikevax** (Moderna), and **Nuvaxovid** (Novavax) are available in Sweden. **Vaxzevria** (AstraZeneca) was used in past, but ceased to be used after 1st September 2021. The latest information on which vaccines are currently in use in Sweden can be found in [emergency information from Swedish authorities](https://www.krisinformation.se/en/hazards-and-risks/disasters-and-incidents/2020/official-information-on-the-new-coronavirus/vaccination-against-covid-19/about-the-vaccines).

### COVID-19 vaccination in the Netherlands

On this page, we explore [publicly available data for COVID-19 vaccination in the Netherlands](https://www.rivm.nl/en/covid-19-vaccination/figures-vaccination-programme).
